Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties
Lets break it down
Production of NAD+ declines sharply with age, leading to hidden cellular damage and visible symptoms like wrinkles, stubborn fat, cognitive fog, delayed recovery, and joint discomfort.[1][2][3] Emerging research suggests that this decline not only accelerates visible aging but also contributes to a cascade of metabolic and neurological issues, making NAD+ restoration a cornerstone of modern anti-aging protocols
My energy level increased and I feel great
The NHS schedule for treating a confirmed deficiency shows why dosing is not guesswork
